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Adult SaudiAbstract The present study is to determine the prevalence and implication of coeliac disease (CD)
among adult Saudis and compared to those with diagnosed irritable bowel syndrome. This prospec-
tive study was conducted among 980 adults. Out of that, 482 subjects (staff and students of Riyadh
Health Science College) were designated as control cohorts for undetected coeliac disease.
Furthermore, another contingent of 498 subjects diagnosed with irritable bowel syndrome (IBS)
at Prince Salman Hospital and Al-Iman General Hospital also constituted a segment of the overall
initial 1020 subjects. Both cases and control were tested for serological markers of coeliac disease
(tissues transglutaminase (tTGAs) and endomysial autoantibody (EMAs) and were conﬁrmed by
histopathology test. All the positive for cases of coeliac disease were screened for iron deﬁciency
anaemia, Vitamin D deﬁciency, and osteoporosis and weight assessment. The percentage of coeliac
disease in control subjects and patients diagnosed with irritable bowel syndrome (IBS) were found
to be 1.9% and 9.6% respectively, about 38% of the total coeliac disease patients are among
females of middle age (20–39-years) and 16% of the males in the same age range. Whereas, 20%
and 25% of all coeliac disease cases with ages of 40–59 were remarked as females and males respec-
tively. The identical nature and overlap of symptoms of the two conditions could possibly result in
misdiagnosis of coeliac diseases or over-diagnosis of irritable bowel syndrome. The ﬁndings of
the study might also give considerable implications of the disease in the nutritional level which is
noticeable.
ª 2015 The Author. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
It is clinically acknowledged that coeliac disease can be
regarded as a potent autoimmune disorder affecting various
body systems. Most individuals that are prone to it are those
who consume rye, barley and wheat that ultimately produce
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et al., 1998). During the digestive process, the taking in of glu-
ten can result in morphological changes in the mucosa of the
small intestine. It then, as corollary affects the smooth opera-
tion of villi, that ultimately results in malabsorption (Sanders
and Hurlston, 2002). Coeliac disease is considered as a unique
gastrointestinal atrophy, which is mainly associated with chil-
dren, though; it has now been observed that is no longer age-
sensitive (Lohi et al., 2007).
The most notable features of coeliac disease’s symptoms
include: defective absorption, (malabsorption), anaemia, insuf-
ﬁciency of iron, debilitating diarrhoea and loss of weight
(Zipser et al., 2003; Green et al., 2001). It is also noticed that
the diminutive body structure is one of the outstanding fea-
tures of the disease. Furthermore, apart from gastrointestinal
symptoms, it is pertinent to say that the disease has certain
traits that are even beyond the familiar intestinal disorders.
Ailments associated with the disease are those related to body
parts such as brain, liver, joints, skin, bone and obstetrics
(Chakravarty and Scott, 1992). It is also validated in other
studies that type 1 diabetes mellitus, thyroid diseases and cer-
tain autoimmune diseases are equally associated with coeliac
disease (Ludvigsson et al., 2005).
Irritable bowel syndrome (IBS) is a chronic functional dis-
order of the gastrointestinal tract of unknown origin.
According to previous studies, incidence of IBS differs depend-
ing on how a manifestation was described and it was also
found that IBS is more common in females and young individ-
uals ranging from 5% to 20% (El-Salhy et al., 2012; Sperber
et al., 2005; Boivin, 2001; Spiegel, 2009). Affected individuals
mostly experience chronic relapsing-remitting course like
symptoms such as lower abdominal pain, diarrhea, and
abdominal bloating or distension (Marsh, 1992; Ford et al.,
2008; Thompson et al., 1999; Manning et al., 1978). Patients
with coeliac disease also reported symptoms like bloating,
abdominal pain, and chronic diarrhoea. Coeliac disease and
irritable bowel syndrome are conditions that have similar
symptoms. Moreover, according to previous studies, individu-
als who are positive with irritable bowel syndrome are prone to
having a coeliac disease compared to controls without irritable
bowel disease (Longstreth et al., 2006). In this study, a much
broader spectrum of individuals have been investigated for
coeliac disease and consequently being diagnosed. This study
aims to determine the prevalence and implication of coeliac
disease (CD) among adult Saudis and make comparison to
those with diagnosed irritable bowel syndrome as there seems
to be a sort of diagnostic haziness between CD and IBS. It is to
be noted that both IBS and coeliac disease share a lot of sim-
ilarities in terms of symptoms; hence, coeliac disease should be
included in the differentiation exercise of diagnosing patients.
On the whole, IBS symptoms often overlap with coeliac
disease.2. Materials and methods
2.1. Subjects and methods
In this study that had been conducted from January 2012 to
January 2013, a total of 1020 subjects aged 20–60 were
involved. Out of that, 482 subjects (staff and students of
Riyadh Health Science College) were designated as controlcohorts for undetected coeliac disease. Furthermore, another
contingent of 498 subjects diagnosed with irritable bowel syn-
drome (IBS) at Prince Salman Hospital and Al-Iman General
Hospital also constituted a segment of the overall initial 1020
subjects. None of the IBS patients was known have CD. We
need to note here that 40 students from the control group
had withdrawn from the control cohort, thus leaving us to
carry out the study validly on 980 subjects. All respondents
answered sets of questionnaires and underwent diagnosis con-
ducted by a physician in accordance with Manning et al. (1978)
and Rome III diagnosis criteria (Longstreth et al., 2006). The
diagnosis questionnaire included GIT symptoms such as diar-
rhoea, vomiting, constipation, dyspepsia, abdominal pain or
discomfort and indigestion related to food and lactose intoler-
ance. Other data about family and subjects’ history included;
diabetes mellitus, abdominal operation, anaemia, osteoporo-
sis, autoimmune diseases and even thyroid disorders. In addi-
tion to the anthropometric measurements, all students and
staff that participated were given a leaﬂet explaining the pur-
pose of the research, a written consent was signed by each par-
ticipant and stating that all the names and personal data would
be decoded and participation was voluntary. All participants
had the right to withdraw at any stage during the study.
This study was approved by ethics committee of research of
college of health sciences.
2.2. Blood measurements and histopathology evaluation
10 ml of venous blood sample was drawn in vacutainer tubes
(Rapid Serum Tubes) without anticoagulant, with 10 min clot-
ting time at room temperature. The blood samples collected
were centrifuged at 4000·g at 4 C for 10 min, and then stored
at 30 C in aliquots of 300 ll for the analysis of the
immunoglobulin A antibodies against human tissue transglu-
taminase (tTG). On the whole, serum samples were proved
positive for IgA antibodies against human tTG by visual
CD-LIA (Imtec-ceoliec disease-LIA, Germany). All Samples
testing positive were measured for EMA known as anti-tTG
antibody against transglutaminase. These were done using a
commercially available enzyme-linked immunosorbent assay
(ELISA; Euroimmun, Germany) kit. The anti-tissue transglu-
taminase IgA ELISA test is an Indirect-solid phase enzyme
Assay for the quantitative measurement of IgA antibodies to
transglutaminase in serum. Autoimmune ELISA kits were
used for diagnostic laboratory procedures carried out accord-
ing to the manufacturers’ instruction for all positive samples.
Biopsy specimens from the second part of the duodenum
were taken from all subjects who proved positive for EMA
against transglutaminase and antigliadin antibodies (AGA).
The procedure includes the following; biopsy specimens were
ﬁxed in formalin, embedded in parafﬁn, sectioned then treated
with haematoxylin–eosin stain in accordance with Marsh
criteria.
3. Results
A total of 980 patients were screened, of which 55 patients
were found to be positive for coeliac disease, 32 were females
and 23 males; age ranged between 20 years and 59 years.
Among the 482 individuals included in the control group, nine
patients were detected with coeliac disease (1.9%) while in the
Table 2 Diseases detected in 55 patients with coeliac disease.
Disease detected Number of patients
Positive Negative
Underweight 40 15
Iron deﬁciency anaemia 19 36
Vitamin D. deﬁciency 37 18
Osteoporosis 34 21
Dermatitis 4 51
464 A.S. Al-Ajlan498 cases diagnosed with irritable bowel syndrome, 48 patients
were detected with coeliac disease having a 5-fold difference.
From Table 1, it is clear that a higher proportion of coeliac
disease was found among females in the middle age group of
20–39 years. 38% of all detected with coeliac disease in the
same age group were females compared to 16% of males. In
the age group of 40–59 years, the prevalence of coeliac disease
was found higher among males, – 25% compared to 20%
among females.
Serological markers of coeliac disease (tTGAs and EMA)
were tested in all 55 cases and controls in the laboratory at
the King Fahd Medical City Laboratory, followed by conﬁr-
mation of diagnosis by a pathologist. 93% of cases were pos-
itive for both tTGAs and EMA, 4.7% of cases were found to
be positive for tTGAs and negative for the EMAs and 2.4% of
cases found to be positive for the EMAs and negative for
tTGAs. Consequently, all the 55 cases tested for histological
diagnosis proved the presence of coeliac disease in all the 55
patients.
The most credible and standard diagnosis of coeliac disease
can be traced to the histopathology description of the disease.
Accordingly, the main pathology of coeliac disease involves
negative serological anti-bodies of the disease, villous atrophy
and crypt hyperplasia with cell inﬁltration in the small bowel.
Of the 55 cases diagnosed in the course of this study, the
repercussions of undetected or latent coeliac disease were cal-
culated thus: Underweight patients constituted 72.7%; those
detected with iron deﬁciency anaemia were 34.5% of the 55
cases, those with vitamin D insufﬁciency had reached 67.3%.
Also, osteoporosis and dermatitis carriers in the group were
61.8% and 7.3%, respectively (Table 2, Fig. 1).
4. Discussion
The study in essence, gives an approximation of the prepon-
derance of serological markers coupled with biopsy-
authenticated coeliac disease with respect to a person carrying
irritable bowel syndrome, (IBS). In the same vein, the study
clearly delineates the prevalence of coeliac disease in adults
that have not been detected despite the fact that there are lim-
ited data on coeliac disease in Saudi Arabia. The dominance of
positive serological results with biopsy-proven coeliac disease
was 1.9% in the control undetected group, while the same pro-
cedure for the irritable bowel syndrome (IBS) patients with
coeliac disease was 9.6%. We need to note here that the cur-
rent results are in virtual agreement with our previous study
(Al-Ajlan, 2013).
In many countries of western hemisphere, it is estimated
that about 1% of the populace are indeed carrying coeliac dis-
ease and studies have shown that in the west, the upsurgeTable 1 Distribution of age and sex ranges in the 55 patients
found to be positive for coeliac disease among 980 individuals.
No. of male patients
with coeliac disease
No. of female patients
with coeliac disease
Age range
5 12 20–29
4 9 30–39
7 7 40–49
7 4 50–59grows correspondingly with the ageing of the population
(Mustalahti et al., 2010). In Scotland, according to recent stud-
ies, the incidence of paediatric coeliac disease increased 6.4-
fold over 20 years (White et al., 2013). Furthermore, in
Finland, according to one report, the incidence of coeliac dis-
ease was 1.5% among children (Ma¨ki et al., 2003), 2% in
adults and 2.7% in the elderly (Vilppula et al., 2009). In the
United States, the prevalence among the populace is about
1% (Alberto et al., 2012). As a result of the serological studies
carried out in Australasia, Europe and South America,
between 0.5 and 1% of the people in these countries carry
the disease undetected (West et al., 2003; Fasano et al.,
2003). The implications of identifying latent coeliac disease
among the populace are not clear as there is a paucity of
reported data arising from few selected cases as regards death
and other psychological features earlier noticed in the latent
coeliac disease.
Furthermore, only few research studies have succeeded in
analyzing the welter of socio-demographic underpinnings with
respect to the disease largely due to low size of the available
sample. Among adults of the general populace, screenings have
captured only a few number of hitherto undiagnosed cases. As
a result, such studies are unable to clearly examine any linkage
in comparison to the people in general (Mustalahti et al.,
1999). In fact, the density of bone mineral and anthropometric
measurement have been the main focal points of the earlier
studies that seek to know the differences between clinically
diagnosed coeliac disease and the undetected ones. Such stud-
ies delineate that people with latent coeliac disease tend to have
insigniﬁcant levels of low bone density and measurements in
line with harmless subnormal nutritional level (Scott et al.,
2000). A study carried out on a cohort in Cambridge, UK,
indicates that negative health effect such as mild anaemia
arises from latent coeliac disease and osteoporosis.
Interestingly, the study implicitly shows a diminished danger
of cardiovascular ailment going by the observation of lower
blood pressure, mass body index and lower serum cholesterol
among persons carrying the latent coeliac disease. Of course,
given the potent consequences of these results, there is a need
to undertake an epidemiological assessment to ascertain it.
The current study is basically aimed at ascertaining the
dominance of coeliac disease among the patients that meet
the conditions of the Rome111 yardstick for irritable bowel
syndrome (IBS) and who were referred to gastroenterology
unit of the Al-Iman General Hospital, Riyadh, within the
gamut of last three years. There is a prevalence of irritable
bowel syndrome of 15–25% among the global population.
On the other hand, the prevalence of coeliac disease is put at
0.5–1% (12, 29). It is to be noted that both IBS and coeliac
Figure 1 Showing repercussions of undetected or latent coeliac disease.
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have virtually similar symptoms, there is a risk that patients
with coeliac disease could be wrongly diagnosed of irritable
bowel syndrome. This apparent risk could be so hazardous
in two irritable bowel syndrome variants such as irritable
bowel syndrome – diarrhoea and irritable bowel syndrome-
mixed. Another potential danger in this situation is that in
both diseases, patients are jolted by taking wheat products.
For coeliac disease, the trigger is due to gluten allergy, while
in the case of irritable bowel syndrome, the effect can emanate
from long sugar polymer fructose found in the wheat (Heizer
et al., 2009).
This study has shown that there are far-reaching conse-
quences for undiagnosed coeliac diseases such as underweight,
osteoporosis, insufﬁciency of iron and vitamin D. Indeed, the
overriding factors in support of this study can be itemized
thus: A-The study participants (both the control and those
with cases of irritable bowel syndrome) were randomly
selected. B-The control and those with cases of IBS tend to
be positive of coeliac disease by testing for both EMAs and
tTGAs antibodies and proven by histological diagnosis. C-
The Canadian Association of Laboratory Medicine has certi-
ﬁed the laboratory used for the analysis of serological antibod-
ies of coeliac disease. This study has used subjects from a wide
age range and gender. However, there are certain limitations to
the study which cannot be ignored. These are: A-The array of
controls and registered cases were not extensive. There was
insufﬁciency of tests regarding allergic and food history in
the patient’s notes and detailed documentation of family.
5. Recommendations
To preclude the problem of over-diagnosis of IBS or misdiag-
nosis of coeliac disease, all patients with IBS should be handled
by an experienced gastroenterology consultant as per the crite-
ria stipulated in Rome111 Classiﬁcation. Since it has been
observed that the symptoms of coeliac disease and IBS tend
to overlap, it would be highly beneﬁcial to carry out serologi-
cal tests for coeliac disease for a person who has IBS symp-
toms. This could be useful as speciﬁc and sensitive test for
diagnosis of coeliac disease. It is clinically valid to adopt theposition of British Society of Gastroenterology that patients
with IBS should, as a matter of urgency, perform full blood
count test plus erythrocyte sedimentation rate and C-reactive
protein, coupled with thyroid function (Spiller et al., 2007).
Given the paucity of research in the area of coeliac disease
and IBS in Saudi Arabia, it will be relevant to undertake fur-
ther research and epidemiological studies with substantial
number of cases. By doing that, the above results could be
solidiﬁed, thus validated.Acknowledgements
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